drugset / Trial / NCT00000445

Use of Naltrexone in a Clinical Setting

NCT00000445

RandomizedOpen-labelTreatment

Summary

This 12-week trial will compare individuals receiving naltrexone or placebo plus substance abuse counseling therapy versus those receiving only substance abuse counseling therapy in a rural, nonacademic setting. A followup period of 12 months is included. The effect on service utilization and the cost of the addition of naltrexone to treatment services for alcohol dependence also will be assessed. The study will expand existing research concerning the effectiveness of naltrexone in clinical trials versus a clinical setting.

Timeline

Start
Primary completion
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule

Indications